A fatal race made Tracee Metcalfe the closest to becoming the first American woman to summit all of the world’s 8,000-meter ...

Dubai: Pakistani mountaineer Asad Ali Memon has achieved a remarkable feat, successfully summiting Mount Vinson, the highest peak in Antarctica. At 4,892 meters, Mount Vinson is not only the tallest ...

His final challenge lies in summiting Puncak Jaya in Indonesia ... (South America), Mount Kilimanjaro (Africa), and Mount Denali (North America). Each climb has tested his endurance, discipline ...

she tells us. However, Everest was not the only peak that tested Kaamya’s limits. Climbing Mount Denali in North America, with its harsh conditions and lack of support, proved to be the most ...

Kenneth M. “Kenny” Goff of Lander died Jan. 4 in an avalanche on the Bridger-Teton National Forest. He was 36. The following was provided by his family. Kenny (formerly of Joshua Tree ...

My family and I purchased the GMC Yukon XL Denali thinking it would be a good vehicle for the family. We could not have been more wrong. We have owned this vehicle for a little over 4 years now.

To him, it felt akin to summiting the highest peak on every continent. I personally think it's even more impressive. Crown Burgers, an historic staple in the Salt Lake City culinary landscape ...

To put it into perspective, climbing one million vertical feet is equivalent to summiting Mount Everest 34 times. Over the past year, Frisch hiked, climbed, and scrambled through 750 hours in the ...

Tenvie Therapeutics has unveiled with $200 million and the goal of transforming the neurological treatment landscape, nabbing several programs—and an executive—from Denali Therapeutics.

A new company is making hay from an R&D shift at Denali Therapeutics, acquiring several of its neuroscience drug candidates and raising money from one of its original investors. The biotech ...

Tenvie Therapeutics has launched with $200 million and a clutch of assets from Denali Therapeutics to go after neurological diseases with small molecules. Backed by ARCH Venture Partners, F-Prime ...

Denali Therapeutics has announced topline results from the phase 2/3 Healey ALS Platform Trial, which evaluated the effects of its drug candidate DNL343. The study did not meet the primary efficacy ...